Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A Novel CAV1-MET Fusion in SCLC Transformation Responds to Crizotinib and Osimertinib Treatment.

× No keyword cloud information.

5 in total

Review 1. Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase.

Authors: Hang-Ping Yao; Xiang-Min Tong; Ming-Hai Wang
Journal: Ther Adv Med Oncol Date: 2021-04-03 Impact factor: 8.168

Review 2. MET-dependent solid tumours - molecular diagnosis and targeted therapy.

Authors: Robin Guo; Jia Luo; Jason Chang; Natasha Rekhtman; Maria Arcila; Alexander Drilon
Journal: Nat Rev Clin Oncol Date: 2020-06-08 Impact factor: 66.675

3. Response to trametinib in a nonsmall cell lung cancer patient with osimertinib resistance harboring GNAS R201C and R201H mutations: a case report.

Authors: You Lv; Chao Zhou; Zhonghai Chen; Xiaokai Zhao; Yonghua Sun; Jieyi Li; Ziying Gong; Daoyuan Zhang; Hai Huang
Journal: Anticancer Drugs Date: 2022-08-09 Impact factor: 2.389

4. Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin.

Authors: Chien-Yu Lin; Sheng-Huan Wei; Yi-Lin Chen; Chung-Ta Lee; Shang-Yin Wu; Chung-Liang Ho; Dean C Pavlick; Po-Lan Su; Chien-Chung Lin
Journal: Front Oncol Date: 2022-08-11 Impact factor: 5.738

Review 5. [Mechanism of Histologic Transformation of Drive Gene Positive Lung Adenocarcinoma in Targeted Therapy and Treatment Strategy].

Authors: Tongji Xie; Yan Li; Puyuan Xing
Journal: Zhongguo Fei Ai Za Zhi Date: 2020-08-06

5 in total